CN Stock MarketDetailed Quotes

603676 Xizang Weixinkang Pharmaceutical

Watchlist
  • 10.74
  • +0.31+2.97%
Market Closed Dec 5 15:00 CST
4.67BMarket Cap18.91P/E (TTM)

About Xizang Weixinkang Pharmaceutical Company

The company was founded in 2002, officially established in 2006, and listed on the main board of the Shanghai Stock Exchange in 2017. Weixinkang currently has 13 subsidiaries, distributed in Beijing, Tibet, Inner Mongolia, Hainan, Jiangsu, Hong Kong, and Singapore. The company is guided by clinical needs, based on R&D and innovation, and adhering to the combination of imitation. It is a comprehensive high-tech pharmaceutical enterprise integrating drug R&D, production and sales, and has significant advantages in the fields of intravenous vitamins, venous trace elements, and intravenous electrolytes. The company's main business is R&D, production and sales of chemical preparations and their raw materials. The company's leading products include injectable multivitamin (12), multi-microelement injection, pediatric multivitamin injection (13), compound electrolyte injection (V), etc. Corporate honors: Inner Mongolia Baiyi Pharmaceutical Master's Student Practice Base; Inner Mongolia Baiyi Pharmaceutical 2015 Trustworthy A-Class Enterprise; New Potassium Biomedical Product Certificate; Inner Mongolia Baiyi Pharmaceutical High-tech Enterprise; Inner Mongolia Baiyi Pharmaceutical Received the Honest Enterprise Certificate, etc.

Company Profile

Short Name-A卫信康
Symbol-A603676
Company NameXizang Weixinkang Pharmaceutical Co., Ltd.
Listing DateJul 21, 2017
Issue Price5.53
Shares Offered63.00M share(s)
FoundedMar 17, 2006
Listed ExchangeSH Stock Exchange
Legal Representativeyong zhang
General Manageryong zhang
Secretaryhaibo yu
Accounting FirmShinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
Legal CounselGuangdong Cinda Law Firm
Employees7
Phone0891-6601760;010-50870100
Office Address3rd Floor, Building 4, Industrial Center, No. 5 Park South Road, Zone B, Lhasa Economic and Technological Development Zone
Zip Code850000
Registered Address3rd Floor, Building 4, Industrial Center, No. 5, Park South Road, Zone B, Lhasa Economic and Technological Development Zone, Tibet
Fax0891-6601760;010-50870100
Emailwxk@wxkpharma.com
Business License540091100002122
BusinessPharmaceutical technology research and development, technology consulting, technology services, technology transfer; introduction and promotion of pharmaceutical technology; information consulting, investment consulting (excluding financial and brokerage business); enterprise management consulting, conference hosting, exhibition services (excluding large-scale performances). [For projects requiring approval according to law, the activity can only be operated after approval by the relevant departments]

Company Executives

  • Name
  • Position
  • Salary
  • yong zhang
  • Chairman, Directors, General Manager, Nomination Committee Members, Chairman of the Strategy Committee
  • 3.00M
  • feng liu
  • Vice Chairman, Directors, Deputy General Manager, Core Technical Personnel, Strategy Committee Members
  • 1.40M
  • binbin liu
  • Directors
  • 1.40M
  • shigong chen
  • Directors, Deputy General Manager, Member of the Remuneration and Assessment Committee
  • 1.10M
  • lei cao
  • Independent Directors, Chairman of the Remuneration and Assessment Committee, Nomination Committee Members, Audit Committee Members
  • 170.00K
  • xiaofang xu
  • Independent Directors, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee
  • 170.00K
  • yanping zhao
  • Independent Directors, Audit Committee Members, Strategy Committee Members, Chairman of the Nomination Committee
  • 170.00K
  • haibo yu
  • Board Secretary
  • 1.00M
  • guotao ning
  • Chairman of the Supervisory Board, Employee Supervisors
  • 634.80K
  • jun wang
  • Auditors
  • 546.50K
  • wan luo
  • Auditors
  • 254.80K
  • xiaobing zhou
  • Deputy General Manager
  • 1.10M
  • zizhong weng
  • Deputy General Manager
  • 1.12M
  • yanxia zheng
  • Chief Financial Officer
  • 801.00K